{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T15:02:58Z","timestamp":1701356578446},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Haemophilia A is an X-linked genetic condition which manifests itself mainly in male children in the first 2\u2009years of life, during gross motor skill development. This disorder is rare in females. The clinical manifestation of severe haemophilia in preterm infants poses a great challenge to the therapeutic team. As extreme prematurity is linked to an increased risk of central nervous system or gastrointestinal bleeding, a well-informed and balanced treatment from the first days of life is crucial to prevent long-term damage.<\/jats:p>\n                <jats:p>Haemophilia is most commonly caused by inheriting defective genes, and can also be linked to skewed X inactivation and Turner syndrome.<\/jats:p>\n                <jats:p>The coincidental occurrence of haemophilia A and Turner syndrome is extremely rare, with only isolated cases described to date. Hence, a multidisciplinary approach is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The authors report on a preterm girl (gestational age 28\u2009weeks) diagnosed with haemophilia and Turner syndrome. The first manifestation of haemophilia was prolonged bleeding from injection sites on the second day of life. Indeterminate aPTT and factor VIII level\u2009&lt;\u20091% confirmed the diagnosis of haemophilia A. Dysmorphic features which did not match the typical clinical picture of haemophilia, the female sex, and a negative paternal family history led to the diagnosis of Turner syndrome. While in hospital, the girl received multiple doses of recombinant factor VIII in response to prolonged bleedings from the injection sites and from a nodule on the girl\u2019s head, and before and after retinal laser photocoagulation. No central nervous system or abdominal cavity bleeding was observed. The substitutive therapy was complicated by the development of factor VIII inhibitor (anti-factor VIII (FVIII) antibodies). Treatment was continued with recombinant factor VIIa. This article aims at demonstrating the complexity of the diagnostics and treatment of a preterm child with two genetic disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Haemophilia should always be considered in the differential diagnosis of prolonged bleeding, even in patients with a negative family history. In the case of coinciding atypical phenotypic features, further diagnostics for another genetic disease are recommended. Infant care should follow current care standards, while considering certain individual features.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-021-01103-7","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:03:26Z","timestamp":1626181406000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe haemophilia A in a preterm girl with Turner syndrome: case report \u2013 a diagnostic and therapeutic challenge for a paediatrician (Part 2)"],"prefix":"10.1186","volume":"47","author":[{"given":"Berendt","family":"Agnieszka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W\u00f3jtowicz-Marzec","family":"Monika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wysoki\u0144ska","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwa\u015bniewska","family":"Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"1103_CR1","unstructured":"Negrier C. Severe hemophilia A. Orphanet encyclopedia https:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search.php?lng=EN&data_id=17872&Disease_Disease_Search_diseaseGroup=Hemophilia-A&Disease_Disease_Search_diseaseType=Pat&Disease(s)\/group%20of%20diseases=Severe-hemophilia-A&title=Severe%20hemophilia%20A&search=Disease_Search_Simple."},{"key":"1103_CR2","unstructured":"Windyga J, Zdziarska J, Zawilska K, \u0141adny JR, Radziwon PM, Jedrzejczak WW, et al. Program Leczenia Chorych na Hemofili\u0119 i Pokrewne Skazy Krwotoczne. https:\/\/www.gov.pl\/documents. Accessed 1 Mar 2020."},{"key":"1103_CR3","unstructured":"World Federation of Hemophilia. Guidelines for the management of hemophilia. 2nd ed: The Federation; 2012. https:\/\/www1.wfh.org\/publications\/files\/pdf-1472.pdf. Accessed 14 Mar 2020"},{"key":"1103_CR4","volume-title":"Genetics Home Reference","author":"Turner syndrome: National Library of Medicine (US)","year":"2020","unstructured":"Turner syndrome: National Library of Medicine (US). Genetics Home Reference. Bethesda: The Library; 2020. Turner syndrome; [reviewed 2017 Oct; cited 2020 Apr 16]; [about 6 screens]. Available from:https:\/\/ghr.nlm.nih.gov\/condition\/turner-syndrome#statistics. Accessed 1Mar 2020"},{"issue":"4","key":"1103_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/hae.13756","volume":"25","author":"E Santagostino","year":"2019","unstructured":"Santagostino E, Riva A, Cesaro S, Esposito S, Matino D, Mazzucchelli RI, et al. Consensus statements on vaccination in patients with haemophilia\u2014results from the Italian haemophilia and vaccinations (HEVA) project. Haemophilia. 2019;25(4):656\u201367. https:\/\/doi.org\/10.1111\/hae.13756 Epub 2019 Apr 16.","journal-title":"Haemophilia"},{"issue":"6","key":"1103_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.ejhg.5201799","volume":"15","author":"NK Renault","year":"2007","unstructured":"Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL. Heritable skewed X-chromosome inactivation leads to haemophilia a expression in heterozygous females. Eur J Hum Genet. 2007;15(6):628\u201337. https:\/\/doi.org\/10.1038\/sj.ejhg.5201799 Epub 2007 Mar 7.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1103_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13052-020-00892-7","volume":"46","author":"A Berendt","year":"2020","unstructured":"Berendt A, W\u00f3jtowicz-Marzec M, Wysoki\u0144ska B, Kwa\u015bniewska A. Severe haemophilia a in a preterm girl with turner syndrome - a case report from the prenatal period to early infancy. Ital J Pediatr. 2020;46(1):125. https:\/\/doi.org\/10.1186\/s13052-020-00892-7.","journal-title":"Ital J Pediatr"},{"key":"1103_CR8","volume-title":"RecombiPlasTin 2G [package insert]","author":"IL Hemos","year":"2019","unstructured":"Hemos IL. RecombiPlasTin 2G [package insert]. Bedford: Instrumentation Laboratory Company; 2019."},{"key":"1103_CR9","volume-title":"HemosIL APTT \u2013 SP (liquid) [package insert]","author":"APTT","year":"2019","unstructured":"APTT. HemosIL APTT \u2013 SP (liquid) [package insert]. Bedford: Instrumentation Laboratory Company; 2019."},{"key":"1103_CR10","volume-title":"Factor VIII deficient plasma [package insert]","author":"IL Hemos","year":"2017","unstructured":"Hemos IL. Factor VIII deficient plasma [package insert]. Bedford: Instrumentation Laboratory Company; 2017."},{"key":"1103_CR11","volume-title":"Factor IX deficient plasma [package insert]","author":"IL Hemos","year":"2008","unstructured":"Hemos IL. Factor IX deficient plasma [package insert]. Bedford: Instrumentation Laboratory Company; 2008."},{"key":"1103_CR12","volume-title":"Factor XI deficient plasma [package insert]","author":"IL Hemos","year":"2017","unstructured":"Hemos IL. Factor XI deficient plasma [package insert]. Bedford: Instrumentation Laboratory Company; 2017."},{"key":"1103_CR13","volume-title":"Factor XI deficient plasma [package insert]","author":"IL Hemos","year":"2018","unstructured":"Hemos IL. Factor XI deficient plasma [package insert]. Bedford: Instrumentation Laboratory Company; 2018."},{"key":"1103_CR14","volume-title":"Von Willebrand Factor Antigen [package insert]","author":"IL Hemos","year":"2016","unstructured":"Hemos IL. Von Willebrand Factor Antigen [package insert]. Bedford: Instrumentation Laboratory Company; 2016."},{"key":"1103_CR15","volume-title":"Von Willebrand Factor Activity [package insert]","author":"IL Hemos","year":"2018","unstructured":"Hemos IL. Von Willebrand Factor Activity [package insert]. Bedford: Instrumentation Laboratory Company; 2018."},{"issue":"6","key":"1103_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1046\/j.1365-2516.1998.00201.x","volume":"4","author":"RF Gale","year":"1998","unstructured":"Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia a using recombinant factor VIII. Haemophilia. 1998;4(6):850\u20133. https:\/\/doi.org\/10.1046\/j.1365-2516.1998.00201.x.","journal-title":"Haemophilia"},{"key":"1103_CR17","first-page":"A9222","volume":"159","author":"LM Kooiman","year":"2015","unstructured":"Kooiman LM, Schroor EJ. A premature infant with increased bleeding tendency: what if the family history of bleeding disorders is negative? Ned Tijdschr Geneeskd. 2015;159:A9222 Dutch.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"6","key":"1103_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3109\/14767058.2013.825600","volume":"27","author":"S Fink","year":"2014","unstructured":"Fink S, Kunzmann S, Andres O, Eyrich M, Wiegering V. Haemophilia in extreme immature preterm infants: increased risk for intracranial haemorrhage? Matern Fetal Neonatal Med. 2014;27(6):621\u20134. https:\/\/doi.org\/10.3109\/14767058.2013.825600.","journal-title":"Matern Fetal Neonatal Med"},{"issue":"4","key":"1103_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1365-2516.2010.02455.x","volume":"17","author":"P Cartledge","year":"2011","unstructured":"Cartledge P, Deakin K, McKecknie L, Richards M. A case report of a premature infant with haemophilia a and factor VIII inhibitor. Haemophilia. 2011 Jul;17(4):711\u20132. https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02455.x.","journal-title":"Haemophilia"},{"issue":"1","key":"1103_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/PEC.0b013e318191db15","volume":"25","author":"KW Feldman","year":"2009","unstructured":"Feldman KW. The bruised premobile infant: should you evaluate further? Pediatr Emerg Care. 2009;25(1):37\u20139. https:\/\/doi.org\/10.1097\/PEC.0b013e318191db15.","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"1103_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2516.2008.01802.x","volume":"15","author":"B Gelbart","year":"2009","unstructured":"Gelbart B, Barnes C. Severe haemophilia and extreme prematurity--a case report. Haemophilia. 2009;15(1):352\u20134. https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01802.x.","journal-title":"Haemophilia"},{"issue":"2","key":"1103_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2516.2007.01645.x","volume":"14","author":"KE Kraft","year":"2008","unstructured":"Kraft KE, Verlaak R, van Heijst AF, Nov\u00e1kov\u00e1 I, Brons PP. Management of haemophilia in three premature infants. Haemophilia. 2008;14(2):378\u201380. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01645.x.","journal-title":"Haemophilia"},{"issue":"2","key":"1103_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00431-004-1542-6","volume":"164","author":"C Bidlingmaier","year":"2005","unstructured":"Bidlingmaier C, Bergmann F, Kurnik K. Haemophilia a in two premature infants. Eur J Pediatr. 2005 Feb;164(2):70\u20132. https:\/\/doi.org\/10.1007\/s00431-004-1542-6.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"1103_CR24","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","volume":"109","author":"SC Gouw","year":"2007","unstructured":"Gouw SC, van der Bom JG, van den Marijke BH. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia a: the CANAL cohort study. Blood. 2007;109(11):4648\u201354. https:\/\/doi.org\/10.1182\/blood-2006-11-056291 Epub 2007 Feb 8.","journal-title":"Blood"},{"issue":"1","key":"1103_CR25","first-page":"12","volume":"10","author":"P Laguna","year":"2017","unstructured":"Laguna P, Klukowska A. Management of children with haemophilia complicated by inhibitor. J Transf Med. 2017;10(1):12\u20138 Polish.","journal-title":"J Transf Med"},{"issue":"1","key":"1103_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/hae.12790","volume":"22","author":"M Carcao","year":"2016","unstructured":"Carcao M, Re W, Ewenstein B. The role of previously untreated patient studies in understanding the development of FVIII inhibitors. Haemophilia. 2016;22(1):22\u201331. https:\/\/doi.org\/10.1111\/hae.12790 Epub 2015 Aug 27.","journal-title":"Haemophilia"},{"issue":"21","key":"1103_CR27","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, et al. A randomized trial of Factor VIII and neutralizing antibodies in hemophilia a. N Engl J Med. 2016;374(21):2054\u201364. https:\/\/doi.org\/10.1056\/NEJMoa1516437.","journal-title":"N Engl J Med"},{"issue":"9","key":"1103_CR28","first-page":"2428","volume":"83","author":"GL Bray","year":"1994","unstructured":"Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, et al. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia a. The Recombinate Study Group. Blood. 1994;83(9):2428\u201335.","journal-title":"Blood"},{"issue":"2","key":"1103_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/hae.13387","volume":"24","author":"H Platokouki","year":"2018","unstructured":"Platokouki H, Fischer K, Gouw SC, Rafowicz A, Carcao M, Kenet G, et al. Vaccinations are not associated with inhibitor development in boys with severe haemophilia a. Haemophilia. 2018;24(2):283\u201390. https:\/\/doi.org\/10.1111\/hae.13387 Epub 2017 Dec 15.","journal-title":"Haemophilia"},{"key":"1103_CR30","unstructured":"World Federation of Hemophilia. Carriers and women with hemophilia: The Federation; 2012. https:\/\/www1.wfh.org\/publication\/files\/pdf-1471.pdf. Accessed 28 Feb 2020."},{"issue":"3","key":"1103_CR31","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"Turner Syndrome Society","year":"2017","unstructured":"Turner Syndrome Society. Clinical practice guidelines for the care of women and girls with turner syndrome: proceedings from the 2016 Cincinnati international turner syndrome meeting. Eur J Endocrinol. 2017;177(3):G1\u2013G70. https:\/\/doi.org\/10.1530\/EJE-17-0430.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1103_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1067\/mpd.2003.95","volume":"142","author":"F Alvarez-Nava","year":"2003","unstructured":"Alvarez-Nava F, Soto M, S\u00e1nchez MA, Fern\u00e1ndez E, Lanes R. Molecular analysis in turner syndrome. J Pediatr. 2003;142(3):336\u201340. https:\/\/doi.org\/10.1067\/mpd.2003.95.","journal-title":"J Pediatr"},{"issue":"9","key":"1103_CR33","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jcem.85.9.6800","volume":"85","author":"CH Gravholt","year":"2000","unstructured":"Gravholt CH, Fedder J, Naeraa RW, M\u00fcller J. Occurrence of gonadoblastoma in females with turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab. 2000;85(9):3199\u2013202. https:\/\/doi.org\/10.1210\/jcem.85.9.6800.","journal-title":"J Clin Endocrinol Metab"},{"key":"1103_CR34","unstructured":"Polskie Towarzystwo Neonatologiczne. Standardy opieki medycznej nad noworodkiem w Polsce. 2nd ed. Warszawa: Media-Press Sp. z o. o; 2017:318."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-021-01103-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-021-01103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:16:47Z","timestamp":1626182207000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-021-01103-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/s13052-021-01103-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2018Not applicable\u2019 for that section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}